Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Celgene
Celgene
Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen
Endpoints
Wed, 08/28/19 - 12:38 pm
Bristol-Myers Squibb
AbbVie
Empliciti
Celgene
Europe
relapsed or refractory multiple myeloma
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Xconomy
Wed, 08/28/19 - 10:55 am
Celgene
cell therapies
drug development
Immatics
cancer
Six burning Otezla questions
EP Vantage
Tue, 08/27/19 - 10:53 pm
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Endpoints
Tue, 08/27/19 - 09:55 am
Bristol-Myers Squibb
Celgene
Presage Biosciences
Phase 0 testing
drug development
Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win
Motley Fool
Mon, 08/26/19 - 10:56 pm
Amgen
Celgene
Otzela
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
How Big Is Celgene's Latest Good News?
Motley Fool
Sun, 08/18/19 - 12:38 pm
Celgene
Otezla
Revlimid
Inrebic
Celgene wins approval for drug key to Bristol buyout
Biopharma Dive
Fri, 08/16/19 - 01:06 pm
Celgene
FDA
Inrebic
myelofibrosis
M&A
Bristol-Myers Squibb
Celgene Continues Growing While Waiting for its Acquisition to Close
Motley Fool
Wed, 08/7/19 - 10:55 am
Celgene
earnings
M&A
Bristol-Myers Squibb
Lift off! Celgene MS effort launches hot air balloon to highlight brain health
Fierce Pharma
Mon, 08/5/19 - 11:14 am
Celgene
multiple sclerosis
MS
ozanimod
drug marketing
Wiping its slate ahead of BMS buy, Celgene to pay $117M in Revlimid antitrust settlements
Fierce Pharma
Fri, 08/2/19 - 12:28 am
Celgene
Bristol-Myers Squibb
antitrust
Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer
Investors Business Daily
Wed, 07/31/19 - 08:50 am
Celgene
earnings
M&A
Bristol-Myers Squibb
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Fierce Pharma
Thu, 07/25/19 - 10:38 pm
Bristol-Myers Squibb
Celgene
M&A
drug pricing
Giovanni Caforio
Why wait? Celgene restructures a big Jounce pact — zeroing in on new I/O pathway with $530M deal and bumping ICOS
Endpoints
Tue, 07/23/19 - 07:53 pm
Celgene
Jounce Therapeutics
JTX-8064
macrophages
FDA Approves First Treatment for Oral Ulcers Associated with Rare Inflammatory Disease
BioSpace
Mon, 07/22/19 - 11:41 am
Otzela
Celgene
FDA
Behcet's disease
Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect
Marketwatch
Mon, 07/22/19 - 10:15 am
Celgene
Biogen
AbbVie
Bristol-Myers Squibb
earnings
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
Gilead Sciences
Amgen
Regeneron
Eli Lilly
JNJ
Celgene bags option on Nimbus' anticancer HPK1 inhibitor
Fierce Biotech
Tue, 07/9/19 - 08:45 am
Celgene
Nimbus Therapeutics
HPK1 inhibitors
Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019
Motley Fool
Mon, 07/8/19 - 10:23 pm
Bristol-Myers Squibb
Celgene
M&A
FDA Action Alert: Karyopharm, Merck and Celgene
BioSpace
Mon, 07/1/19 - 10:54 pm
FDA
Karyopharm
Selinexor
Merck
relebactam
Celgene
Otezla
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »